Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 57Mesothelioma 35Unspecified Adult Solid Tumor, Protocol Specific 25Solid Tumor 9Advanced Solid Tumors 8Advanced Solid Tumor 7Solitary Fibrous Tumor, Pleural 6Carcinoma, Non-Small-Cell Lung 6Sarcoma 4Lung Neoplasms 4Solid Tumors 3Peritoneal Neoplasms 3Neoplasms 3Stomach Neoplasms 2Retinoblastoma 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Extensive Stage Small Cell Lung Cancer 2Colorectal Neoplasms 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms 2Advanced Solid Tumour 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

adavosertib 5durvalumab 3Paclitaxel 3olaparib 2ceralasertib 2Fluorouracil 2Carboplatin 2toripalimab 1sintilimab 1pembrolizumab 1factor IX, factor VII, factor X, prothrombin drug combination 1drug XX Z 1danvatirsen 1capivasertib 1Rifampin 1Pantoprazole 1Omeprazole 1Leucovorin 1Itraconazole 1Irinotecan 1Injections 1Gemcitabine 1Doxorubicin 1Cisplatin 1AZD0156 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumours × Cisplatin × Other solid neoplasm × Clear all
NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

AstraZeneca

Phase 1 Completed
76 enrolled
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡